$4.79
0.04[0.84%]
At close: Apr 23
$4.4385
-0.3515[-7.34%]
After Hours: 5:07PM EDT
Aileron Therapeutics
(NASDAQ:ALRN)Aileron Therapeutics Stock (NASDAQ:ALRN), Analyst Ratings, Price Targets, Predictions
Aileron Therapeutics Inc has a consensus price target of $6.67, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Ladenburg Thalmann, Ladenburg Thalmann, and HC Wainwright & Co. on April 18, 2024, December 1, 2023, and June 30, 2022. With an average price target of $9.67 between Ladenburg Thalmann, Ladenburg Thalmann, and HC Wainwright & Co., there's an implied 117.79% upside for Aileron Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Ladenburg Thalmann
HC Wainwright & Co.
William Blair
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Aileron Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/18/2024 | ALRN | Buy Now | Aileron Therapeutics | $4.44 | 328.07% | Ladenburg Thalmann | Aydin Huseynov | $9 → $19 | Maintains | Buy | Get Alert |
| 12/01/2023 | ALRN | Buy Now | Aileron Therapeutics | $4.44 | 102.77% | Ladenburg Thalmann | Aydin Huseynov | → $9 | Upgrade | Neutral → Buy | Get Alert |
| 06/30/2022 | ALRN | Buy Now | Aileron Therapeutics | $4.44 | -77.47% | HC Wainwright & Co. | Edward White | $40 → $20 | Maintains | Buy | Get Alert |
| 06/29/2022 | ALRN | Buy Now | Aileron Therapeutics | $4.44 | — | William Blair | Matt Phipps | — | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Aileron Therapeutics (ALRN)?
The latest price target for Aileron Therapeutics (NASDAQ: ALRN) was reported by Ladenburg Thalmann on April 18, 2024. The analyst firm set a price target for $19.00 expecting ALRN to rise to within 12 months (a possible 296.66% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aileron Therapeutics (ALRN)?
The latest analyst rating for Aileron Therapeutics (NASDAQ: ALRN) was provided by Ladenburg Thalmann, and Aileron Therapeutics maintained their buy rating.
When was the last upgrade for Aileron Therapeutics (ALRN)?
The last upgrade for Aileron Therapeutics Inc happened on December 1, 2023 when Ladenburg Thalmann raised their price target to $9. Ladenburg Thalmann previously had a neutral for Aileron Therapeutics Inc.
When was the last downgrade for Aileron Therapeutics (ALRN)?
The last downgrade for Aileron Therapeutics Inc happened on June 29, 2022 when William Blair changed their price target from N/A to N/A for Aileron Therapeutics Inc.
When is the next analyst rating going to be posted or updated for Aileron Therapeutics (ALRN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aileron Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aileron Therapeutics was filed on April 18, 2024 so you should expect the next rating to be made available sometime around April 18, 2025.
Is the Analyst Rating Aileron Therapeutics (ALRN) correct?
While ratings are subjective and will change, the latest Aileron Therapeutics (ALRN) rating was a maintained with a price target of $9.00 to $19.00. The current price Aileron Therapeutics (ALRN) is trading at is $4.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.